Products for Research Use Only
RegisterLogin

DA 3003-2

CAT: 0804-HY-118798-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-118798-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
DA 3003-2 is a potent and selectively Cdc25 inhibitor. DA 3003-2 shows antiproliferative activity. DA 3003-2 induces cell cycle arrest at the G2/M phase and increases the expression of P-tyr15 Cdc2. DA 3003-2 has the potential for the research of prostate cancer[1].
CAS Number
383907-47-9
Product Name Alternative
NSC663285
UNSPSC
12352005
Target
Phosphatase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/da-3003-2.html
Purity
98.36
Solubility
DMSO : 150 mg/mL (ultrasonic)
Smiles
O=C(C1=C(C2=O)N=CC=C1)C(NCCN3CCOCC3)=C2Cl
Molecular Formula
C15H16ClN3O3
Molecular Weight
321.76
References & Citations
[1]Nemoto K. G2/M accumulation in prostate cancer cell line PC-3 is induced by Cdc25 inhibitor 7-chloro-6- (2-morpholin-4-ylethylamino) quinoline-5, 8-dione (DA 3003-2) . Exp Ther Med. 2010 Jul;1 (4) :647-650.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture and light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-D0158ZnAF-2 DA
HY-107500-01UVI 3003
HY-1786203'-O-Phthalimido-2'-dA
HY-W036167DMT-2'-F-dA Phosphoramidite
HY-W093086-01DMT-2'-F-Bz-dA
HY-1785363'-O-NH2-2'-dA
HY-1572002,4-DA-6-FP
HY-162158DA ZP1
HY-122148DA 4626
HY-162454DA-023

Alternative Products

CatalogName
T69316-01DA 3003-2
IQA90747-01DA-3003-2
B7353-5UVI 3003
A20010-1UVI 3003 1mg

Popular Products